EUVIMEDEUVIMED entdecken
Open Access

Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis

Leticia Cardoso Valente iD, Julia Stocco da Silva, Luana Riechelmann-Casarin, Fernando Gomes Romeiro, Luís Fernando Barbisan, Guilherme Ribeiro Romualdo iD

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.71017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Leticia Cardoso Valente und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Research Unit (UNIPEX), Botucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil. Hauptthemen laut MEDLINE: Sorafenib, Liver Neoplasms, Carcinoma, Hepatocellular, Caffeine. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Universidade Estadual Paulista (PIBIC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) features a high mortality burden worldwide, highlighting the need for improved therapeutic strategies. Caffeine (CAF), a widely consumed bioactive compound, has been reported to exert chemopreventive effects in HCC, but its interaction with standard therapies remains poorly explored. We investigated whether CAF enhances the antitumor effects of sorafenib (SOR) chemotherapy in preclinical HCC models. C3H/HeJ mice were submitted to diethylnitrosamine (DEN)‐induced hepatocarcinogenesis and treated with CAF (50 mg/kg), SOR (30 mg/kg), or their combination for 3 weeks. C3A+LX2 spheroids and transwell co‐cultures were also exposed to CAF, SOR, or their combination at 1/5 or 1/10 of the half‐maximal effective concentration. The combination of CAF and SOR produced a synergistic reduction in tumor spheroid viability, consistent with the transcriptomic alterations observed, and inhibited HCC cell colony formation. Nonetheless, treatments exerted comparable effects on reducing liver tumor volume and Afp expression in vivo. Although only CAF + SOR reduced serum ALT levels and uniquely downregulated HCC‐related Ccl3 , treatments showed differential and subtle transcriptomic impacts in DEN‐induced hepatocarcinogenesis, with no promoting or additive effects when combined. In summary, while CAF potentiated SOR antitumoral activity in vitro, their combination did not lead to major effects in vivo, eliciting the need for further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibLiver NeoplasmsCarcinoma, HepatocellularCaffeineCarcinogenesisAntineoplastic Combined Chemotherapy ProtocolsHumansAnimalsMiceMaleMice, Inbred C3HHep G2 CellsSpheroids, CellularGene Expression ProfilingDiethylamines

Stichwörter der Autor:innen

caffeinediethylnitrosaminehepatocellular carcinomasorafenibspheroids

Substanzen

SorafenibCaffeineN-nitrodiethylamineDiethylamines

Autor:innen und Institutionen

  • Experimental Research Unit (UNIPEX), Botucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil.
  • Botucatu Medical School, São Paulo State University (UNESP), Botucatu, SP, Brazil.
  • Department of Structural and Functional Biology, Botucatu Biosciences Institute, São Paulo State University (UNESP), Botucatu, SP, Brazil.

ORCID-Profile: Leticia Cardoso Valente, Guilherme Ribeiro Romualdo

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Universidade Estadual Paulista (PIBIC)

Zitieren

APA

Valente, L. C., Silva, J. S. D., Riechelmann-Casarin, L., Romeiro, F. G., Barbisan, L. F., & Romualdo, G. R. (2026). Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.71017

Vancouver

Valente LC, Silva JSD, Riechelmann-Casarin L, Romeiro FG, Barbisan LF, Romualdo GR. Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.71017

BibTeX
@article{Valente2026,
  author = {Valente, Leticia Cardoso and Silva, Julia Stocco da and Riechelmann-Casarin, Luana and Romeiro, Fernando Gomes and Barbisan, Luís Fernando and Romualdo, Guilherme Ribeiro},
  title = {Caffeine in the Context of Sorafenib Chemotherapy: Insights From Experimental Hepatocarcinogenesis},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.71017}
}
Kostenlos starten →